VALUGEN PHARMA LIMITED
Significant control: Benno Ranjitkumar Sabapathy (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Valugen Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Valugen Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
VALUGEN PHARMA LIMITED is an active private limited company (company number 11693165) incorporated on 23 November 2018, registered in Harrow. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 30 November 2025, showing net assets of −£2,014 and cash of £13k, with 0 employees on average. Net assets fell 61% on the prior period (−£1,250). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the bottom quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).
Ownership and control
- Mr Benno Ranjitkumar Sabapathy
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 23 November 20187 yrs ago
- Next accounts due
- 30 August 2027in 307 days
- Confirmation statement due
- 7 December 2026in 41 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£2,014 | £13k | £2,895 | £27k | — | — | 0 |
| 30 November 2024 | −£1,250 | £8,047 | £8,187 | — | — | — | 0 |
| 30 November 2023 | −£2,490 | £9,819 | £5,864 | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-2,014 at 30 November 2025
- Net assets down 25% or more on the prior period-61.1% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.93
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 23 November 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 307 days
- Confirmation statement duein 41 days
- Accounts period endNet liabilities £2,014 · small accounts
- Accounts period endNet liabilities £1,250 · small accounts
- Accounts period endNet liabilities £2,490 · small accounts
- Incorporated
Similar companies in Greater London
- CELLTRION HEALTHCARE UNITED KINGDOM LIMITEDUxbridge · inc. Nov 2018
- RAPID PHARMA LIMITEDWatford · inc. Dec 2018
- CELLCHEM UK LIMITEDSouthall · inc. Nov 2018
- SPECIALS PHARMA LTDDagenham · inc. Dec 2018
- MTK LIFE LTDHarrow · inc. Dec 2018
- FARMAKO LIMITEDCroydon · inc. Oct 2018
All companies incorporated on 23 November 2018 · in Nov 2018.
Reminders for VALUGEN PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.